RIPK1 Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice.
Circulation
; 143(2): 163-177, 2021 01 12.
Article
in En
| MEDLINE
| ID: mdl-33222501
Full text:
1
Database:
MEDLINE
Main subject:
NF-kappa B
/
Inflammation Mediators
/
Gene Silencing
/
Atherosclerosis
/
Receptor-Interacting Protein Serine-Threonine Kinases
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Year:
2021
Type:
Article